Minneapolis, Minnesota
CNS clinical trials in Minneapolis, MN
48 CNS studies are recruiting participants at sites in Minneapolis as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Minneapolis at a glance
- 48 studies are recruiting at a site in Minneapolis.
- By phase: Early Phase 1 (3), Phase 1 (2), Phase 1/2 (1), Phase 2 (1), Phase 3 (7), Phase 4 (1), No phase (23), Observational (10). Studies of devices and behavioral approaches have no phase.
- By sponsor: university, hospital or other (33), industry (11), government (4).
- By research area: Parkinson's Disease (19), Depression (13), Epilepsy (5), Migraine (4), Schizophrenia (4), ADHD (2), Bipolar Disorder (1).
- Most recent update to one of these records: November 16, 2026.
Depression studies recruiting in Minneapolis
Basic details from each study's public record (the 30 most recently updated of 48). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- LivaNova
- Study site
- University of Minnesota
- Registry record
- NCT03887715 · updated
Study of ALTO-300 in MDD
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Alto Neuroscience
- Registry record
- NCT05922878 · updated
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- No phase
- Ages 22 to 70
- All sexes
- Sponsor
- Abbott Medical Devices
- Study site
- University of Minnesota Medical Center Fairview
- Registry record
- NCT06423430 · updated
Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- VA Office of Research and Development
- Study site
- Minneapolis VA Health Care System, Minneapolis, MN
- Registry record
- NCT05491538 · updated
Effect of Vagal Nerve Stimulation on Gastric Motor Functions
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- University of Minnesota
- Registry record
- NCT06038929 · updated
RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Boston University
- Study site
- VA Minneapolis Healthcare System
- Registry record
- NCT06906302 · updated
Transdiagnostic Cognitive Biomarkers
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- University of Minnesota
- Study site
- University of Minnesota
- Registry record
- NCT04864080 · updated
PCS in Severe Treatment Resistant Depression
- No phase
- Ages 22 to 70
- All sexes
- Sponsor
- University of Minnesota
- Study site
- University of Minnesota
- Registry record
- NCT04124341 · updated
Cognitive Strategies in Early Psychosis 2
- Phase 3
- Ages 18 to 35
- All sexes
- Sponsor
- University of Minnesota
- Study site
- University of Minnesota
- Registry record
- NCT07263022 · updated
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
- No phase
- Ages 13 to 21
- All sexes
- Sponsor
- University of Minnesota
- Study site
- University of Minnesota
- Registry record
- NCT05652153 · updated
Cognitive and Affective Processes Online
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- University of Minnesota
- Study site
- University of Minnesota
- Registry record
- NCT05736471 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Minneapolis, MN on ClinicalTrials.gov.
Schizophrenia studies recruiting in Minneapolis
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
- No phase
- Ages 18 to 59
- All sexes
- Sponsor
- Washington University School of Medicine
- Study site
- University of Minnesota
- Registry record
- NCT07853807 · updated
Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 3
- No phase
- Ages 18 to 59
- All sexes
- Sponsor
- Washington University School of Medicine
- Study site
- University of Minnesota
- Registry record
- NCT07900893 · updated
State Representation in Early Psychosis 2
- Observational
- Ages 15 to 45
- All sexes
- Sponsor
- University of Minnesota
- Study sites
- University of Minnesota Ambulatory Research Center · University of Minnesota Department of Psychology
- Registry record
- NCT07834203 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Minneapolis, MN on ClinicalTrials.gov.
ADHD studies recruiting in Minneapolis
The Myelin Disorders Biorepository Project
- Observational
- All ages
- All sexes
- Sponsor
- Children's Hospital of Philadelphia
- Study site
- University of Minnesota
- Registry record
- NCT03047369 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Minneapolis, MN on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Minneapolis
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Registry record
- NCT06989112 · updated
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Minnesota Oncology Hematology, PA ( Site 8003)
- Registry record
- NCT06952504 · updated
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Allina Health Cancer Institute - Abbott Northwestern Hospital ( Site 0115)
- Registry record
- NCT06170788 · updated
Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease
- No phase
- Ages 21 to 76
- All sexes
- Sponsor
- University of Minnesota
- Study site
- Movement Disorders Laboratory
- Registry record
- NCT07226284 · updated
Kinematic and Neural Dynamics of Postural Instability in Parkinson's Disease
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- VA Office of Research and Development
- Study site
- Minneapolis VA Health Care System, Minneapolis, MN
- Registry record
- NCT06405334 · updated
Bayesian Optimization of DBS for Gait
- Early Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- University of Minnesota
- Study site
- University of Minnesota
- Registry record
- NCT07835308 · updated
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
- Phase 4
- Ages 40 and older
- All sexes
- Sponsor
- VA Office of Research and Development
- Study site
- Minneapolis VA Health Care System, Minneapolis, MN
- Registry record
- NCT04373317 · updated
Pathways Mediating Impaired Postural Control in Parkinson's Disease
- Observational
- Ages 45 to 80
- All sexes
- Sponsor
- University of Minnesota
- Study site
- University of Minnesota
- Registry record
- NCT06464029 · updated
Imaging Core Aim 2, and Udall Project 2 Aim 2
- No phase
- Ages 21 and older
- All sexes
- Sponsor
- University of Minnesota
- Study site
- University of Minnesota
- Registry record
- NCT06998303 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Minneapolis, MN on ClinicalTrials.gov.
Epilepsy studies recruiting in Minneapolis
Diagnosing Epilepsy To EffeCT Change
- No phase
- Ages 18 to 75
- All sexes
- Sponsor
- Epiminder America, Inc.
- Study site
- University of Minnesota
- Registry record
- NCT07110337 · updated
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
- Observational
- Ages 18 to 75
- All sexes
- Sponsor
- Epiminder America, Inc.
- Study site
- University of Minnesota
- Registry record
- NCT07110454 · updated
Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy
- Early Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- University of Minnesota
- Study site
- University of Minnesota
- Registry record
- NCT05493722 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Minneapolis, MN on ClinicalTrials.gov.
Migraine studies recruiting in Minneapolis
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- Clinical Research Institute
- Registry record
- NCT07645924 · updated
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- Clinical Research Institute
- Registry record
- NCT07674654 · updated
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Phase 1
- Ages 6 to 11
- All sexes
- Sponsor
- Pfizer
- Study site
- Clinical Research Institute
- Registry record
- NCT06995729 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Minneapolis, MN on ClinicalTrials.gov.
Ask about studies near Minneapolis
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Minnesota
All Minnesota locations
92 studies recruiting across 13 cities.
Rochester
39 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections